<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05088304</url>
  </required_header>
  <id_info>
    <org_study_id>JinlingHospital-1</org_study_id>
    <secondary_id>201502022</secondary_id>
    <nct_id>NCT05088304</nct_id>
  </id_info>
  <brief_title>GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer</brief_title>
  <official_title>The Application Value of Preoperative Fat-free Mass Index Within GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jinling Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jiangsu Cancer Institute &amp; Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Subei People's Hospital of Jiangsu Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jinling Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims to investigate the prognostic value of preoperative fat-free mass&#xD;
      index for postoperative outcomes in patients undergoing esophagogastric cancer surgery, and&#xD;
      to explore the role of the FFMI in the Global Leadership Initiative on Malnutrition (GLIM)&#xD;
      criteria.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The GLIM criteria of malnutrition as a consensus lack of optimal combination in clinical&#xD;
      validation. After the publication of the GLIM consensus, few studies have examined the effect&#xD;
      of reduced FFMI on the clinical prognosis of patients with esophagogastric cancer, and&#xD;
      whether the FFMI can be used as an effective diagnostic criterion of malnutrition in&#xD;
      esophagogastric cancer needs to be further studied.&#xD;
&#xD;
      Therefore, the present study aims were to investigate the prognostic value of preoperative&#xD;
      fat-free mass index for postoperative outcomes in patients undergoing esophagogastric cancer&#xD;
      surgery, and to explore the role of the FFMI in the GLIM consensus for malnutrition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2015</start_date>
  <completion_date type="Actual">July 1, 2018</completion_date>
  <primary_completion_date type="Actual">June 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>Within 60 days after surgery</time_frame>
    <description>postoperative complications (infectious complications and noninfectious complications)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of stay (LOS)</measure>
    <time_frame>Within 60 days after surgery</time_frame>
    <description>length of stay (LOS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound healing time</measure>
    <time_frame>Within 60 days after surgery</time_frame>
    <description>wound healing time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative antibiotic time</measure>
    <time_frame>Within 60 days after surgery</time_frame>
    <description>postoperative antibiotic time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nutritional status</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>nutritional status ( such as: weight，albumin，prealbumin)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalization cost</measure>
    <time_frame>Within 60 days after surgery</time_frame>
    <description>hospitalization cost(including: surgery and medicine costs)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">205</enrollment>
  <condition>Cancer of Stomach</condition>
  <condition>Cancer of Esophagus</condition>
  <condition>Malnutrition</condition>
  <condition>Muscle Loss</condition>
  <arm_group>
    <arm_group_label>The normal FFMI group</arm_group_label>
    <description>The FFMI was calculated as follows: FFMI = fat-free mass (kg)/height squared (m2). FFMI cut-off values (derived from BIA measurements, &lt;/≥15 kg/m2 for females and &lt;/≥17 kg/m2 for males). Patients with esophagogastric cancer were then divided into the normal FFMI group (FFMI ≥17 kg/m2 for male and FFMI ≥15 kg/m2 for female).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The low FFMI group</arm_group_label>
    <description>The FFMI was calculated as follows: FFMI = fat-free mass (kg)/height squared (m2). FFMI cut-off values (derived from BIA measurements, &lt;/≥15 kg/m2 for females and &lt;/≥17 kg/m2 for males). Patients with esophagogastric cancer were then divided into the low FFMI group (FFMI &lt;17 kg/m2 for male and FFMI &lt;15 kg/m2 for female).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <arm_group_label>The low FFMI group</arm_group_label>
    <arm_group_label>The normal FFMI group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elective surgery for esophagogastric cancer (there was a clear pathological diagnosis&#xD;
        before surgery)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Elective surgery for esophagogastric cancer (there was a clear pathological diagnosis&#xD;
        before surgery); NRS2002≥3; Preoperative BIA examination was performed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Discharged from a hospital within 24 hours; No BIA examination and not suitable for BIA&#xD;
        examination (such as ascites, edema, amputation and pace-maker); Hepatic insufficiency&#xD;
        (alanine transaminase/aspartate transaminase ratio 200% above normal range or&#xD;
        bilirubin&gt;3mg/dL) ; Renal insufficiency (serum creatinine&gt;1.5mg/dL); Emergency operation;&#xD;
        Pregnancy; Missing the postoperative information follow-up data.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2021</study_first_posted>
  <last_update_submitted>October 10, 2021</last_update_submitted>
  <last_update_submitted_qc>October 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jinling Hospital, China</investigator_affiliation>
    <investigator_full_name>Wang Xinying</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>FFIM</keyword>
  <keyword>GLIM</keyword>
  <keyword>Cancer</keyword>
  <keyword>Postoperative complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

